Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
2(17%)
Results Posted
22%(2 trials)

Phase Distribution

Ph phase_3
2
17%
Ph phase_2
2
17%
Ph phase_4
1
8%
Ph phase_1
5
42%
Ph not_applicable
1
8%

Phase Distribution

5

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
5(45.5%)
Phase 2Efficacy & side effects
2(18.2%)
Phase 3Large-scale testing
2(18.2%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
1(9.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

90.0%

9 of 10 finished

Non-Completion Rate

10.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

12

all time

Status Distribution
Active(2)
Completed(9)
Terminated(1)

Detailed Status

Completed9
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 15 (45.5%)
Phase 22 (18.2%)
Phase 32 (18.2%)
Phase 41 (9.1%)
N/A1 (9.1%)

Trials by Status

withdrawn18%
active_not_recruiting18%
completed975%
recruiting18%

Recent Activity

2 active trials
Showing 5 of 12
completedphase_1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

NCT02858310
completedphase_1

Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

NCT05470881
completedphase_3

Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children

NCT06697522
withdrawnphase_1

Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution

NCT05481489
recruitingphase_2

Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.

NCT06327399
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT02858310Phase 1

E7 TCR T Cells for Human Papillomavirus-Associated Cancers

Completed
NCT05470881Phase 1

Phase I Clinical Trial to Evaluate the Safety and Tolerability of Ophtalmic Solution PRO-201

Completed
NCT06697522Phase 3

Study of Atropine Sulfate Eye Drops(0.01%) in Treating Near-work-induced Transient Myopia in Children

Completed
NCT05481489Phase 1

Safety and Tolerability Evaluation of PRO-230 Ophthalmic Solution

Withdrawn
NCT06327399Phase 2

Dexmedetomidine Infusion Dose Versus Rapid Bolus Dose Before Tracheal Intubation.

Recruiting
NCT03690089Phase 2

Low-dose Atropine Eye Drops to Reduce Progression of Myopia in Children in the United Kingdom

Active Not Recruiting
NCT05683535

Adverse Events Related to Low Dose Atropine

Completed
NCT05372991Phase 1

Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop

Completed
NCT04505228Not Applicable

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

Completed
NCT03932578Phase 4

Intrathecal Atropine vs IV Metoclopramide for Nausea & Vomiting During CS

Completed
NCT01858090Phase 3

Intrathecal Levobupivacaine With Opioids for Caesarean Section

Completed
NCT00947596Phase 1

A Study of Inhaled Atropine Sulfate in Healthy Adults

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12